Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume
Sang-Wook Shin, Woo Kyoung Jeong, Sanghyeok Lim, Yongsoo Kim, Jinoo Kim
Clin Mol Hepatol. 2015;21(1):71-79. Published online 2015 Mar 25 DOI: https://doi.org/10.3350/cmh.2015.21.1.71
Citations to this article as recorded by 
Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh Class A Liver function: A Pilot Study
Feiqian Wang, Kazushi Numata, Satoshi Komiyama, Haruo Miwa, Kazuya Sugimori, Katsuaki Ogushi, Satoshi Moriya, Akito Nozaki, Makoto Chuma, Litao Ruan, Shin Maeda
Frontiers in Oncology.2022;[Epub] CrossRef
Hepatoprotective support during radiofrequency ablation in patients with colorectal liver metastases
S. V. Vertyankin, O. M. Konopatskova
Onkologiya. Zhurnal imeni P.A.Gertsena.2019; 8(5): 375. CrossRef
Feasibility of Percutaneous Intrahepatic Split by Microwave Ablation (PISA) After Portal Vein Embolization for Hypertrophy of Future Liver Remnant: The Radiological Stage-1 ALPPS
Alessandro Lunardi, Rosa Cervelli, Duccio Volterrani, Saverio Vitali, Carlo Lombardo, Giulia Lorenzoni, Laura Crocetti, Irene Bargellini, Daniela Campani, Luca Emanuele Pollina, Roberto Cioni, Davide Caramella, Ugo Boggi
CardioVascular and Interventional Radiology.2018;[Epub] CrossRef